BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8958939)

  • 1. Murine models of cancer cytokine gene therapy using interleukin-12.
    Tahara H; Zitvogel L; Storkus WJ; Robbins PD; Lotze MT
    Ann N Y Acad Sci; 1996 Oct; 795():275-83. PubMed ID: 8958939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
    Tahara H; Zitvogel L; Storkus WJ; Zeh HJ; McKinney TG; Schreiber RD; Gubler U; Robbins PD; Lotze MT
    J Immunol; 1995 Jun; 154(12):6466-74. PubMed ID: 7759882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.
    Zitvogel L; Robbins PD; Storkus WJ; Clarke MR; Maeurer MJ; Campbell RL; Davis CG; Tahara H; Schreiber RD; Lotze MT
    Eur J Immunol; 1996 Jun; 26(6):1335-41. PubMed ID: 8647214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
    Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
    BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
    Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
    J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of interleukin 12 to antitumor cytokine and gene therapy.
    Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
    Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM; Cronin K; Bannerji R; Golde DW; Gansbacher B
    Blood; 1994 Mar; 83(5):1289-98. PubMed ID: 8118032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production.
    Tan J; Crucian BE; Chang AE; Aruga E; Aruga A; Dovhey SE; Tanigawa K; Yu H
    J Immunother; 1998 Jan; 21(1):48-55. PubMed ID: 9456436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.
    Pappo I; Tahara H; Robbins PD; Gately MK; Wolf SF; Barnea A; Lotze MT
    J Surg Res; 1995 Feb; 58(2):218-26. PubMed ID: 7861776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.
    Zitvogel L; Tahara H; Cai Q; Storkus WJ; Muller G; Wolf SF; Gately M; Robbins PD; Lotze MT
    Hum Gene Ther; 1994 Dec; 5(12):1493-506. PubMed ID: 7711142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
    Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
    Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone.
    Sun Y; Qian C; Peng D; Prieto J
    Hum Gene Ther; 2000 Jan; 11(1):127-38. PubMed ID: 10646645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.